48 related articles for article (PubMed ID: 15629612)
1. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
Cesaretti JA; Stock RG; Lehrer S; Atencio DA; Bernstein JL; Stone NN; Wallenstein S; Green S; Loeb K; Kollmeier M; Smith M; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):196-202. PubMed ID: 15629612
[TBL] [Abstract][Full Text] [Related]
2. Global analysis of ATM polymorphism reveals significant functional constraint.
Thorstenson YR; Shen P; Tusher VG; Wayne TL; Davis RW; Chu G; Oefner PJ
Am J Hum Genet; 2001 Aug; 69(2):396-412. PubMed ID: 11443540
[TBL] [Abstract][Full Text] [Related]
3. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence.
Edvardsen H; Tefre T; Jansen L; Vu P; Haffty BG; Fosså SD; Kristensen VN; Børresen-Dale AL
Radiat Oncol; 2007 Jul; 2():25. PubMed ID: 17623063
[TBL] [Abstract][Full Text] [Related]
4. ATM missense variant P1054R predisposes to prostate cancer.
Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
[TBL] [Abstract][Full Text] [Related]
5. An appraisal of genetic testing for prostate cancer susceptibility.
Finch A; Clark R; Vesprini D; Lorentz J; Kim RH; Thain E; Fleshner N; Akbari MR; Cybulski C; Narod SA
NPJ Precis Oncol; 2022 Jun; 6(1):43. PubMed ID: 35732815
[TBL] [Abstract][Full Text] [Related]
6. Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers.
Clark R; Herrera-Caceres J; Kenk M; Fleshner N
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205755
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variants of DNA Repair Genes as Predictors of Radiation-Induced Subcutaneous Fibrosis in Oropharyngeal Carcinoma.
Gupta A; Mathew D; Bhat SA; Ghoshal S; Pal A
Front Oncol; 2021; 11():652049. PubMed ID: 34079756
[TBL] [Abstract][Full Text] [Related]
8. Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications.
Toh M; Ngeow J
Oncologist; 2021 Sep; 26(9):e1526-e1537. PubMed ID: 34021944
[TBL] [Abstract][Full Text] [Related]
9. Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.
Balázs K; Antal L; Sáfrány G; Lumniczky K
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33924671
[TBL] [Abstract][Full Text] [Related]
10. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
Karlsson Q; Brook MN; Dadaev T; Wakerell S; Saunders EJ; Muir K; Neal DE; Giles GG; MacInnis RJ; Thibodeau SN; McDonnell SK; Cannon-Albright L; Teixeira MR; Paulo P; Cardoso M; Huff C; Li D; Yao Y; Scheet P; Permuth JB; Stanford JL; Dai JY; Ostrander EA; Cussenot O; Cancel-Tassin G; Hoegel J; Herkommer K; Schleutker J; Tammela TLJ; Rathinakannan V; Sipeky C; Wiklund F; Grönberg H; Aly M; Isaacs WB; Dickinson JL; FitzGerald LM; Chua MLK; Nguyen-Dumont T; ; Schaid DJ; Southey MC; Eeles RA; Kote-Jarai Z
Eur Urol Oncol; 2021 Aug; 4(4):570-579. PubMed ID: 33436325
[TBL] [Abstract][Full Text] [Related]
11. Increased radiation toxicity with germline ATM variant of uncertain clinical significance.
Mullins BT; Gupta G
Rep Pract Oncol Radiother; 2019; 24(6):672-680. PubMed ID: 31719806
[TBL] [Abstract][Full Text] [Related]
12. Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.
Zanusso C; Bortolus R; Dreussi E; Polesel J; Montico M; Cecchin E; Gagno S; Rizzolio F; Arcicasa M; Novara G; Toffoli G
Oncotarget; 2017 Apr; 8(14):22863-22875. PubMed ID: 28206966
[TBL] [Abstract][Full Text] [Related]
13. Development of a prediction model for radiosensitivity using the expression values of genes and long non-coding RNAs.
Wang WA; Lai LC; Tsai MH; Lu TP; Chuang EY
Oncotarget; 2016 May; 7(18):26739-50. PubMed ID: 27050376
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression.
Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Herrera-Ramos E; Rodríguez-Gallego C; Rodríguez-Melcón JI; Lara PC
BMC Med Genet; 2014 Dec; 15():143. PubMed ID: 25540025
[TBL] [Abstract][Full Text] [Related]
15. Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.
Reuther S; Szymczak S; Raabe A; Borgmann K; Ziegler A; Petersen C; Dikomey E; Hoeller U
Strahlenther Onkol; 2015 Jan; 191(1):59-66. PubMed ID: 25156511
[TBL] [Abstract][Full Text] [Related]
16. The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.
Van den Broeck T; Joniau S; Clinckemalie L; Helsen C; Prekovic S; Spans L; Tosco L; Van Poppel H; Claessens F
Biomed Res Int; 2014; 2014():627510. PubMed ID: 24701578
[TBL] [Abstract][Full Text] [Related]
17. Investigation of genetic polymorphisms related to the outcome of radiotherapy for prostate cancer patients.
Cintra HS; Pinezi JC; Machado GD; de Carvalho GM; Carvalho AT; dos Santos TE; Marciano RD; Soares Rde B
Dis Markers; 2013; 35(6):701-10. PubMed ID: 24324286
[TBL] [Abstract][Full Text] [Related]
18. Reducing rectal injury during external beam radiotherapy for prostate cancer.
Valdagni R; Rancati T
Nat Rev Urol; 2013 Jun; 10(6):345-57. PubMed ID: 23670182
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.
Schoenfeld JD; Margalit DN; Kasperzyk JL; Shui IM; Rider JR; Epstein MM; Meisner A; Kenfield SA; Martin NE; Nguyen PL; Kantoff PW; Giovannucci EL; Stampfer MJ; Mucci LA
Clin Cancer Res; 2013 Mar; 19(6):1612-9. PubMed ID: 23382116
[TBL] [Abstract][Full Text] [Related]
20. Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoin.
Kelsey CR; Jackson IL; Langdon S; Owzar K; Hubbs J; Vujaskovic Z; Das S; Marks LB
Clin Lung Cancer; 2013 May; 14(3):267-74. PubMed ID: 23313170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
